Clinical characteristics and risk factors of acute lymphoblastic leukemia in children with severe infection during maintenance treatment

被引:1
|
作者
Yin, Tiantian [1 ]
Han, Juan [1 ]
Hao, Jinjin [1 ]
Yu, Hui [1 ]
Qiu, Yining [1 ]
Xu, Jiawei [1 ]
Peng, Yun [1 ]
Wu, Xiaoyan [1 ]
Jin, Runming [1 ]
Zhou, Fen [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat, Wuhan 430022, Peoples R China
来源
CANCER MEDICINE | 2023年 / 12卷 / 19期
关键词
acute lymphoblastic leukemia; children; maintenance phase; risk factors; severe infection; GRANULOCYTE TRANSFUSIONS; PEDIATRIC-PATIENTS; INDUCTION THERAPY; CANCER; PNEUMONIA; COMPLICATIONS;
D O I
10.1002/cam4.6495
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Infection is the most common adverse event of acute lymphoblastic leukemia (ALL) treatment and is also one of the main causes of death.Methods: To investigate the clinical characteristics and risk factors of severe infections during the maintenance phase of ALL treatment, we conducted a retrospective study.Results: A total of 181 children were eligible and 46 patients (25.4%) suffered from 51 events of severe infection, most of which occurred in the first half year of the maintenance phase (52.9%). The most common infection was pulmonary infection (86.3%) followed by bloodstream infection (19.6%). The main symptoms of ALL patients with pulmonary infection were fever, cough, and shortness of breath. The main manifestations of computer tomography (CT) were ground glass shadow (56.8%), consolidation shadow (27.3%), and streak shadow (25%). Multivariate binary logistic regression analysis showed that agranulocytosis, agranulocytosis >= 7 days, anemia, and low globulin level were independent risk factors for severe infection during the maintenance phase (all p < 0.05).Conclusions: Taken together, blood routine examinations and protein levels should be monitored regularly for ALL patients in the maintenance phase, especially in the first 6 months. For ALL patients with risk factors, preventive anti-infective or supportive therapies can be given as appropriate to reduce the occurrence of severe infections.
引用
收藏
页码:19372 / 19382
页数:11
相关论文
共 50 条
  • [1] Clinical Features and Risk Factors of Severe Pneumonia in Children With Acute Lymphoblastic Leukemia
    Liu, Chun-yan
    Li, Cheng
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [2] RELAPSE FACTORS DURING MAINTENANCE THERAPY OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN
    HAYDER, S
    BJORK, O
    NILSSON, B
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1992, 9 (01) : 21 - 27
  • [3] Maintenance Treatment in Acute Lymphoblastic Leukemia: A Clinical Primer
    Shekhar Krishnan
    Ananya Mahadevan
    Tushar Mungle
    Manash Pratim Gogoi
    Vaskar Saha
    Indian Journal of Pediatrics, 2024, 91 : 47 - 58
  • [4] Maintenance Treatment in Acute Lymphoblastic Leukemia: A Clinical Primer
    Krishnan, Shekhar
    Mahadevan, Ananya
    Mungle, Tushar
    Gogoi, Manash Pratim
    Saha, Vaskar
    INDIAN JOURNAL OF PEDIATRICS, 2024, 91 (01): : 47 - 58
  • [5] Incidence and risk factors for hypoglycemia during maintenance chemotherapy in pediatric acute lymphoblastic leukemia
    Rosenfeld, Elizabeth
    Getz, Kelly D.
    Miller, Tamara P.
    Seif, Alix E.
    Fisher, Brian T.
    Burrows, Evanette
    Ramos, Mark Jason
    De Leon, Diva D.
    Aplenc, Richard
    Morales, Knashawn H.
    Guevara, James P.
    PEDIATRIC BLOOD & CANCER, 2022, 69 (06)
  • [6] The Risk Factors for Thrombosis in Children With Acute Lymphoblastic Leukemia
    Sivaslioglu, Selda
    Gursel, Turkiz
    Kocak, Ulker
    Kaya, Zuhre
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 (06) : 651 - 653
  • [7] Decrease of Immunoglobulins in Children on Maintenance Treatment for Acute Lymphoblastic Leukemia
    Vasquez, Marta Rojas
    Black, Karina
    McKillop, Sarah
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S37 - S38
  • [8] Dexamethasone in the maintenance phase of treatment for acute lymphoblastic leukemia: Is the risk of severe infections too high?
    De Bont, ES
    Nijhuis, CSO
    Nijhuis, I
    Beishuizen, A
    Bokkerink, J
    Revesz, T
    Kamps, WA
    BLOOD, 2003, 102 (11) : 237B - 237B
  • [9] PHARMACOKINETICS OF ERYTHROCYTE METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA DURING MAINTENANCE TREATMENT
    SCHRODER, H
    CLAUSEN, N
    OSTERGAARD, E
    PRESSLER, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 16 (02) : 190 - 193
  • [10] Serum Immunoglobulin Levels in Children With Acute Lymphoblastic Leukemia During Maintenance Chemotherapy and its Correlation With Intensity of Treatment and Infection
    Trivedi, M.
    Thankamony, P.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S135 - S135